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ABSTRACT 
An effective clearance of microbes is crucial in host defense during infection. In the present 
study, we demonstrate that CC chemokine receptor 8 (CCR8) skews innate immune response 
during septic peritonitis induced by cecal ligation and puncture (CLP). CCR8 was expressed in 
resident peritoneal macrophages and elicited leukocytes during CLP in the wild-type CCR8+/+ 
mice. CCR8−/− mice were resistant to CLP-induced lethality relative to CCR8+/+ mice, and this 
resistance was associated with an augmented bacterial clearance in CCR8−/− mice. In vitro, 
peritoneal macrophages from CCR8−/− mice, but not neutrophils, exhibited enhanced bactericidal 
activities relative to those from CCR8+/+ mice. Upon stimulation with the bacterial component 
LPS, elevated levels of superoxide generation, lysosomal enzyme release, and nitric oxide 
generation, effector molecules for bacterial killing were detected in CCR8−/− macrophages 
relative to CCR8+/+ macrophages. In addition, CCR8−/− macrophages produced significantly 
higher levels than CCR8+/+ macrophages of several cytokines and chemokines known to augment 
bactericidal activities of leukocytes that include TNF-α, IL-12, macrophage-derived chemokine 
(MDC/CCL22), macrophage inflammatory protein (MIP)-2, and KC. Altogether, these results 
indicate that CCR8 may have a negative impact on host defense during septic peritonitis, 
providing a new paradigm for the role of CCR8 in innate immunity. 
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ecruitment of leukocytes into inflammatory foci is the first-line of host defense in 
infection, enabling the host to achieve effective and efficient removal of microbes (1). 
Chemokines are crucial in this process, attracting and activating leukocytes that bear 
specific chemokine receptors. Chemokine receptors constitute a large superfamily and are 
classified into four subtypes, depending on which chemokine subfamily is recognized (2, 3). 
Recent studies have demonstrated that chemokine receptors are preferentially expressed on 
R 
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specific leukocyte subpopulations. For example, Th1 cells express CC chemokine receptor 
(CCR)5 and CXC chemokine receptor (CXCR)3, whereas Th2 cells are associated with CCR3, 
CCR4, and CCR8 (4). 
In addition to being expressed on in vitro polarized Th2 cells, CCR8 has been detected in T cells 
from asthma patients, a Th2-dominant disorder (5). CCR8−/− mice demonstrate impaired Th2 
response in animal models of granuloma and allergic airway inflammation where Th2 cells play 
a central role (6), albeit the role of CCR8 in allergic airway disease is controversial (7, 8). Thus, 
studies to date in the context of CCR8 have focused attention on adaptive immunity. However, 
CCR8 was originally identified on monocytes (9), and T cell activation-specific gene 3 
(TCA3)/CCL1, a ligand for CCR8, is chemotactic for monocytes/macrophages and neutrophils 
(10, 11). Because infiltrating macrophages and neutrophils are essential for bacterial killing in 
infection (12), including septic peritonitis (13, 14), it seemed possible that CCR8 may play a role 
in the innate immunity. 
To identify the functional role of CCR8 in bacterial infection, we used CCR8−/− mice and 
examined the innate immune response during septic peritonitis induced by cecal ligation and 
puncture (CLP). CLP is a clinically relevant model of intra-abdominal sepsis, which develops 
slowly and simulates a polymicrobial enteric insult similar to that seen in patients with colonic 
perforations (15). In the present study, we demonstrate for the first time that mice with CCR8 
deficiency are resistant to CLP-induced lethality, resulting from augmented innate immune 
responses. These results provide a new paradigm for the role of CCR8 in host defense during 
sepsis. 
MATERIALS AND METHODS 
Mice 
CCR8−/− mice (6) were backcrossed 10 generations onto the C57BL/6 mice (Charles River 
Laboratories, Wilmington, MA). Age- and sex-matched C57BL/6 mice were used as wild-type 
CCR8+/+ mice. All chemokine receptors examined (CCR1-11, CXCR1-6, XCR1, CX3CR1, 
DARC, and D6), but CCR8 were similarly expressed in CCR8−/− mice relative to CCR8+/+ mice 
as assessed by quantitative PCR using specific primers for each chemokine receptor (data not 
shown). Cell populations in the resident peritoneal cells were similar between CCR8+/+ and 
CCR8−/− mice as estimated by flow cytometry (F4/80 positive cells, 36–40%; B 220 positive 
cells, 20–24%; Thy1.2 positive cells, 11–16%). Mice were used in all experiments under specific 
pathogen-free conditions. 
In vivo experimental protocol 
CLP surgery was performed as described elsewhere (13, 15). In brief, mice were anesthetized 
and the cecum was exposed, ligated with a 3–0 silk suture below the ileocecal valve, and 
punctured through and through once with a 21-gauge needle. To determine mice survival, CLP-
mice were monitored for 7 days after CLP. In the different set of experiments, CLP mice were 
anesthetized, bled, and killed at appropriate intervals after CLP. The peritoneal cavities were 
washed with 2 ml of sterile saline, and the lavage fluids were harvested under sterile conditions. 
Peritoneal lavage fluids and peripheral blood (10 μl) from each mouse were serially diluted with 
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sterile saline, and 5 μl of each dilution was plated on trypticase soy agar (TSA) plates with 5% 
sheep blood and incubated overnight at 37°C, after which the number of aerobic bacteria 
colonies was counted. The remaining lavage fluids were centrifuged at 6000 g for 1 min at 4°C, 
and cell-free peritoneal fluids were stored at –80°C. Cell pellets were resuspended in saline, and 
the cell numbers were counted in a hemocytometer. Differential cell analyses were made by 
Diff-Quik staining of the smear slides. Smear slides were also used for immunocytochemistry. In 
other experiments, mice were intraperitoneal inoculated with live bacteria (1×108 CFU/mouse) 
recovered from CCR8+/+ mice undergone CLP. The peritoneal lavage fluids at 24 h after the 
inoculation were serially diluted with sterile saline, and 5 μl of each dilution was plated on TSA-
blood plates, incubated overnight at 37°C, and the CFU was counted. 
Quantitative PCR 
Chemokine receptor expression was quantitated by quantitative RT-PCR. Briefly, total RNA was 
isolated from resident macrophages, treated with DNase I and reverse-transcribed using Random 
Hexamer as primers and reverse transcriptase. cDNA (25 ng) was amplified in a mixture of 
SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) and primers using 
GeneAmp 7700 (50°C for 2 min, 95°C for 10 min, 40 cycles of 95°C for 15 s, and 60°C for 1 
min; Applied Biosystems). CCR8 primers are sense, 5′-
TGACCGACTACTACCCTGATTTCTT-3′ and antisense, 5′-GCTGCCCCTGAGGAGGAA-3′. 
Target gene expression was shown as relative values compared with the amount of ubiquitin 
cDNA in samples. Ubiquitin primers are sense, 5′-TGGCTATTAATTATTCGGTCTGCAT-3′ 
and antisense, 5′-GCAAGTGGCTAGAGTGCAGAGTAA-3′. 
Western blotting 
Cells were dissolved in Laemmli buffer (1×106/50 μl), sonicated, boiled, fractionated on SDS-
polyacrylamide gel (10 μl), and transferred to a nitrocellulose membrane. After blocking with 
TBS-T (Tris-buffered saline+0.1% Tween-20) containing 5% skim milk for 1 h at room 
temperature, the membrane was incubated with goat anti-murine CCR8 IgG (Alexis 
Biochemicals, San Diego, CA) overnight at 4°C. After washing with TBS-T, the membrane was 
incubated with rabbit anti-goat Fab’ conjugated to peroxidase-labeled dextran polymer (Nichirei 
Co., Tokyo, Japan) for 1 h at room temperature and visualized with an enhanced 
chemiluminescence system (Cell Signaling Inc., Beverly, MA). 
Immunocytochemistry 
Cytospin preparations were fixed immediately in 100% methanol. After blocking endogenous 
peroxidase using 0.3% H2O2 in methanol, we rehydrated the slides in Tris-buffered saline (TBS) 
and blocked with 10% normal goat serum for 1 h at room temperature. The slides were incubated 
with goat anti-murine CCR8 IgG (Alexis Biochemicals) or control goat IgG at 5 μg/ml in TBS-
1% BSA overnight at 4°C. After being washed with TBS-tween 20 (0.1%), the slides were 
incubated with rabbit anti-goat IgG conjugated to horseradish peroxidase (HRP)-labeled dextran 
polymer (EnVision plus, Peroxidase: DakoCytomation, Carpinteria, CA) for 30 min at room 
temperature. After washing, the reaction was developed with diaminobenzidine (Sigma, St. 
Louis, MO). Counter-staining was done with hematoxylin. 
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In vitro phagocytic and killing activities of leukocytes 
Peritoneal cells were harvested from non-treated mice, suspended in antibiotic-free RPMI 
medium containing 10% FCS, and cultured for 1 h at 37°C in two 24-well culture dishes 
(1.5×106/well). Non-adherent cells were removed, and the adherent macrophages were infected 
with 1 × 106 CFU of live bacteria, which were recovered from the peritoneum of CCR8+/+ mice 
at 24 h after CLP. After 1 h-incubation, the wells were washed out to remove unphagocytized 
bacteria, and the cells in one plate were lysed with sterile 0.5% Triton X-100 for bacterial 
phagocytosis assay. Wells in the other plate were replaced with pre-warmed fresh medium and 
incubated for an additional 2 h, after which the cells were lysed with 0.5% Triton X-100 for 
bacterial killing assay (14). The lysates were serially diluted, plated on TSA-blood plates, and 
incubated overnight at 37°C, and the numbers of aerobic colonies were counted. In other 
experiments, infiltrating leukocytes were harvested at 6 h after intraperitoneal injection of 1 ml 
of 4% thioglycollate (Difco Laboratories, Detroit, MI). Neutrophils were isolated from the 
elicited leukocytes by Ficoll gradient centrifugation (neutrophil purity >94%). To determine in 
vitro bactericidal activities of neutrophils, a classical CFU assay was used with minor 
modifications (16). In brief, cells were infected with 1 × 106 CFU of live bacteria recovered from 
CLP-mice. Control wells contained only bacteria. After being cultured for 4 h in a 5% CO2 
incubator, plates were placed at –80°C for 30 min and cells were lysed by thawing. This did not 
affect bacteria viability, as determined in control experiments. The lysates were serially diluted, 
plated on TSA-blood plates, and incubated overnight at 37°C, and the number of aerobic 
colonies was counted. Bactericidal activity was expressed as % bacteria death = [CFU from 
control wells (without cells) – CFU from experimental wells]/[CFU from control wells (without 
cells)] × 100. 
Cell culture 
Adherent macrophages from resident peritoneal cells (1.5×106/well) were cultured in RPMI 1640 
supplemented with 10% FCS, glutamine, and antibiotics in a 5% CO2 incubator with or without 
the bacterial component LPS (1 μg/ml, E. coli 0111, B4: Difco Laboratories, Detroit, MI). After 
24 h, the culture supernatants were harvested and centrifuged at 6000 g for 1 min at 4°C, and 
cell-free supernatants were stored at –80°C. The culture supernatants were used for 
measurements of cytokines, lysosomal enzyme release, and nitric oxide (NO) production. The 
lysosomal enzyme release was determined by β-glucuronidase activity, according to the methods 
described previously (17). NO level was determined by measuring nitrite and nitrate, stable end 
products of nitric oxide metabolism, using Colorimetric enzymatic NO assay kit (Oxford 
Biomedical Research, Oxford, MI). 
The superoxide production from cells was measured using the reduction of ferricytochrome c 
(14, 18). In brief, adherent peritoneal macrophages or peripheral neutrophils purified by Ficoll 
gradient centrifugation (1×106/well) were cultured in phenol red-free RPMI 1640 containing 
cytochrome c (1.3 mg/ml, Sigma), and stimulated with LPS (1 μg/ml) for 30 min, and the 
supernatants were measured spectrophotometrically at 550 nm as a function of ferricytochrome c 
reduction. 
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Cytokine ELISAs 
Murine cytokines were measured using a standard method of sandwich ELISA, as described (19, 
20). The captured antibodies, detection antibodies, and recombinant cytokines were purchased 
from R&D Systems (Minneapolis, MN). The ELISAs used in this study did not cross-react with 
other murine cytokines available, and they consistently detected murine cytokine concentrations 
above 30 pg/ml. 
Statistics 
Statistical significance was evaluated by ANOVA. In case of survival curve and CFU count, the 
data were analyzed by the log-rank test and Mann-Whitney test, respectively. A P < 0.05 value 
was regarded as statistically significant. All data were expressed as mean ± SEM. 
RESULTS 
Expression of CCR8 in peritoneal leukocytes during CLP 
In our initial experiments, we examined whether CCR8 was expressed in peritoneal leukocytes 
during CLP. Freshly isolated peripheral blood mononuclear cells, purified by Ficoll gradient 
centrifugation, showed negligible level of CCR8 expression as estimated by RT-PCR and 
Western blot (data not shown). The CCR8 mRNA expression was detected in resident peritoneal 
macrophages from CCR8+/+ mice (Fig. 1A). Immunocytochemistry revealed that CCR8 protein 
was present on the resident macrophages (Fig. 1B). CCR8 was also detected in elicited 
leukocytes obtained from CCR8+/+ mice that underwent CLP as examined by Western blot (Fig. 
1C). At this time point, infiltrating macrophages and neutrophils were stained with anti-CCR8 
IgG, and the overall staining intensity was stronger than resident macrophages (Fig. 1B). Thus, 
CCR8 was expressed in both resident macrophages and elicited leukocytes (macrophages and 
neutrophils) during CLP, but not in peripheral blood mononuclear cells, in CCR8+/+ mice. In 
contrast, resident peritoneal macrophages as well as elicited leukocytes during CLP from 
CCR8−/− mice did not express CCR8 (Fig. 1A, C). No positive staining was observed in CCR8−/− 
macrophages (not shown). 
CCR8−/− mice were resistant to CLP-induced lethality 
To determine the functional role of CCR8 in host defense during CLP, survival rates in CCR8+/+ 
and CCR8−/− mice were monitored after CLP. The data in Fig. 2 demonstrated that all CCR8−/− 
mice (23/23) survived for 2 days after CLP, whereas 12 out of 21 CCR8+/+ mice were dead on 
day 2. Of the 23 CCR8−/− mice, 21 survived for 7 days; whereas only 5 CCR8+/+ mice (5/21) 
survived for 7 days (P<0.0001, Fig. 2). These data clearly demonstrate that CCR8–/– mice are 
resistant to the lethality induced by CLP. 
Increased bacterial clearance in CCR8−/− mice 
Bacterial burden is tightly associated with the mortality in the CLP model where infiltrating 
leukocytes play a central role (13, 14). To identify the basis whereby CCR8−/− mice were 
resistant to CLP, bacterial burden and leukocyte infiltration in CLP-mice were investigated. 
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Although bacterial burden at 6 h post CLP was unchanged between CCR8+/+ and CCR8−/− mice, 
CCR8−/− mice displayed an increased bacterial clearance at 24 h post CLP, as indicated by 
smaller numbers of recovered CFU counts in the peritoneum (Fig. 3A). The mean peritoneal 
CFU count in CCR8−/− mice was a 103-fold lower than that in CCR8+/+ mice. At this time point, 
bacteremia was observed in 4/16 of CCR8+/+ mice, but not in CCR8−/− mice (0/13) (Fig. 3B). 
Enhanced bacterial clearance in CCR8−/− mice was also observed when mice were 
intraperitoneally received live bacteria (1×108 CFU/mouse) recovered from CCR8+/+ mice 
undergone CLP (Fig. 3C). On the other hand, no statistical differences were found in the number 
of infiltrating neutrophils and macrophages at 6 and 24 h after CLP between CCR8+/+ and 
CCR8−/− mice (not shown). Thus, CCR8−/− mice cleared bacteria much more effectively than 
CCR8+/+ mice without augmenting the leukocyte infiltration, suggesting that bactericidal 
activities of leukocytes may be augmented in CCR8−/− mice. 
Augmented innate immune response in CCR8−/− macrophages 
We, therefore, examined the phagocytic and killing activities of peritoneal macrophages and 
neutrophis from CCR8+/+ and CCR8−/− mice. As shown in Table 1, the CFU counts inside 
macrophages after 1 h culture were similar between CCR8+/+ and CCR8−/− mice, suggesting an 
equal phagocytic activity of the cells. After an additional 2 h culture, the CFU counts inside 
CCR8−/− macrophages were significantly lower than CCR8+/+ macrophages (Table 1). In 
contrast, in vitro bactericidal activities of neutrophils were not augmented in CCR8−/− 
neutrophils. Effector molecules for bacterial killing were subsequently examined in the culture 
supernatants of LPS-stimulated peritoneal macrophages, which included superoxide anion (O2–) 
generation, lysosomal enzyme (β-glucronidase) release, and NO production (21). As shown in 
Fig. 4A, CCR8−/− macrophages produced higher levels of these molecules than CCR8+/+ 
macrophages. Superoxide generation in CCR8−/− neutrophils was not augmented upon 
stimulation with LPS (data not shown). Thus, CCR8−/− macrophages, but not neutrophils, 
exhibited enhanced bactericidal activities when compared with CCR8+/+ cells. 
Next we investigated the ability of peritoneal macrophages to secrete cytokines known to 
augment the bactericidal activities of leukocytes. For this, CCR8+/+ and CCR8−/− macrophages 
were cultured in the presence or absence of LPS, and cytokine levels in the supernatants were 
measured. The data in Fig. 4B demonstrated that CCR8−/− macrophages produced significantly 
higher levels of TNFα, IL-12, and macrophage-derived chemokine (MDC)/CCL22 than CCR8+/+ 
macrophages. Elevated levels of the neutrophil activating chemokines macrophage inflammatory 
protein (MIP)-2 and KC were also detected in the supernatants of CCR8−/− macrophages relative 
to CCR8+/+ macrophages (Fig. 4B). Higher production of cytokines and chemokines by CCR8−/− 
macrophages could represent an important mechanism favoring bacterial removal from the 
CCR8−/− hosts. 
Altered cytokine response and prevention of renal injury in CCR8−/− mice 
Effective bacteria killing in CCR8−/− mice may lead to decreased systemic response followed by 
CLP. Subsequently, plasma levels of several cytokines and organ damage after CLP were 
investigated. The data in Fig. 6 demonstrated that CCR8−/− mice displayed 60 and 41% decreases 
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in plasma levels of TNFα and IL-12, respectively, although they were not statistically 
significant. However, anti-inflammatory cytokine IL-10 and IL-13 were significantly augmented 
in CCR8−/− mice, compared with CCR8+/+ mice (Fig. 5). Kidney is a major target organ during 
sepsis, and the dysfunction can be fatal to the host (23). CLP caused an elevation in the level of 
blood urea nitrogen (BUN) and creatinine in CCR8+/+ mice, representing renal injury in this 
model (Fig. 6). In CCR8−/− mice, levels of BUN and creatinine after CLP were comparable with 
those from untreated mice (Fig. 6). Thus, CCR8−/− mice evaded renal injury induced by CLP, an 
event that was associated with an altered cytokine balance in favor of anti-inflammatory effects. 
DISCUSSION 
Effective host defense against bacterial infection is dependent on the recruitment and activation 
of phagocytic cells (21), which is governed by chemokine and chemokine receptors (2, 3). In the 
present study, we provide evidence suggesting that the chemokine receptor CCR8 may have a 
novel and unexpected role that is important in innate immunity. Most of the work on this 
receptor thus far has focused on its potential role in adaptive immunity. The findings presented 
here now implicate CCR8 in innate immunity and constitute the first example of negative 
regulation of innate immunity by a chemokine receptor. 
The increased survival of the CCR8−/− mice in the CLP model of sepsis was associated with an 
enhanced bactericidal activity of the CCR8−/− macrophages. In this context, altered neutrophil 
function may account for the different degree of bacterial clearance during CLP, as 
approximately two-thirds of infiltrating leukocytes were neutrophils. Despite the presence of 
CCR8 on infiltrating neutrophils, in vitro superoxide generation as well as bacteria killing of 
neutrophils were not augmented in CCR8−/− mice relative to CCR8+/+ mice. Thus, neutrophils did 
not appear to directly contribute to the altered bacterial clearance in CCR8−/− mice. Although 
macrophages may influence bactericidal activity of neutrophils, allowing CCR8−/− mice to 
achieve effective innate immunity, our present data suggest that ablation of CCR8 function on 
macrophages appears to have an unexpected positive impact on innate immune response during 
septic peritonitis. 
The results in the present study raise several questions, such as: Are the local levels of the 
murine CCR8 ligand TCA3 altered during peritonitis, and if so, does TCA3 favor development 
of septic peritonitis? Our results suggest that direct ligation of CCR8 by TCA3 does not seem to 
favor the development of septic peritonitis in wild-type CCR8+/+ mice. Appreciable levels of 
TCA3 were not detected in the peritoneum during CLP (0.05±0.02 and 0.20±0.07 ng/ml, 6 and 
24 h post-CLP, respectively, 6 mice each). TCA3 (10–100 ng/ml) did not reduce cytokine 
production from LPS-stimulated macrophages or in vitro bactericidal activities of peritoneal 
macrophages. Furthermore, intraperitoneal injection of TCA3 (1 μg/mouse) at the time of CLP-
surgery did not induce increased bacterial load in the peritoneum or bacteremia during CLP (our 
own unpublished observations). Other CCR8 ligand(s) may provide bacteria with environmental 
niche. In this context, thymus and activation-regulated cytokine (TARC/CCL17) and 
macrophage inflammatory protein-1 β (MIP-1β/CCL4) can be the possible ligand (24), but 
others demonstrate that these chemokines do not bind CCR8 at physiologically relevant 
concentrations (25). CCR8 may be constitutively active, as this has been reported for some viral 
chemokine receptors (26, 27) and could be relevant in this particular model. Endogenous 
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antagonist(s) may cause the negative regulation, however, no such molecules have been 
identified to date in humans or mice. MC148, a virally encoded CCR8 antagonist, has been 
identified in the genome of the human poxvirus molluscum contagiosum (28). Viral chemokines 
such as vMIP-II and vMCC-1 act as potent antagonists without inducing signaling (29), which 
suggests the existence of molecules with similar properties in humans and mice. Identification of 
CCR8 ligands or molecules with antagonistic activity against CCR8 remains to be established. 
Finally, and perhaps more importantly, why are the CCR8−/− macrophages more efficient at 
mounting bactericidal responses? Could CCR8 interfere with innate immune responses? In the 
present study, we showed that no appreciable level of CCR8 was found in peripheral blood 
mononuclear cells, but the expression was evident in peritoneal resident macrophages. CCR8 
expression was augmented in the elicited leukocytes during CLP. Consistent with our 
observations, Trebst et al. have recently demonstrated that CCR8 expression on monocytes is up-
regulated in response to monocyte/macrophage-activating stimuli, despite no appreciable CCR8 
expression in peripheral blood monocytes (30). Thus, CCR8 expression appears to be associated 
with macrophage differentiation and/or activation status. An attractive hypothesis is that CCR8 
may interfere with innate immune responses by regulating differentiation of macrophages. 
Studies done by Qu et al. suggest that this may be occurring in the CCR8−/− mice. Their results 
indicate that different sets of monocytes are recruited into the peritoneum of CCR8+/+ and 
CCR8−/− mice after intraperitoneal challenge of thioglycollate. Nearly half of the monocytes in 
CCR8+/+ mice differentiated into DC after 2 days culture in the presence of GM-CSF; whereas 
only a small number of monocytes from CCR8−/− did so (31). These are intriguing observations 
because it has been shown that monocytes/macrophages that differentiate into DC-like cells 
mount poor innate immune responses (22, 32). Thus, signaling through CCR8 may actually 
control the differentiation of macrophages and favor the accumulation in the peritoneum of 
CCR8−/− macrophages with higher bactericidal activities. Up-regulated LPS-induced cytokine 
response in CCR8−/− macrophages could be associated with the developmental fate of 
macrophages. 
Failure in restricting the invading pathogens to a localized area of tissue results in an 
overwhelming systemic response via an enhanced cytokine/chemokine production, leading to 
systemic inflammatory response syndrome (SIRS) (33). This is likely the mechanism whereby 
CCR8−/− mice are resistant to septic peritonitis induced by CLP. In this model, the CCR8−/− mice 
evaded renal injury during CLP as evidenced by clinical chemistry. Of interest was the 
observation that plasma cytokine response during CLP in CCR8−/− mice was balanced in favor of 
anti-inflammatory effects. Although effective bacteria clearance in CCR8−/− mice appears to be 
primarily responsible for the reduced production of TNFα and IL-12, augmented production of 
anti-inflammatory cytokines is expected to play a role in decreasing the level of TNFα and IL-
12, possibly contributing to an alleviation of renal injury. Studies are required to elucidate how 
CCR8 regulates cytokine balance during CLP. 
We have thus far elucidated important roles of chemokine–chemokine receptor system in an 
innate immunity during CLP. For instance, CC chemokines CCL2/MCP-1, CCL3/MIP-1α, 
CCL6/C10, and CCL22/MDC are beneficial to the septic peritonitis by augmenting an innate 
immune response (13, 14, 20, 34, 35). Thus, inflammatory responses governed by chemokines 
are primarily beneficial to the host defense during CLP. However, an excessive inflammation 
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appears to be pathologic, as neutralization of macrophage inflammatory protein (MIP)-2 and its 
receptor CXCR2, which plays a crucial role in neutrophil infiltration/activation, is deleterious to 
the host (36, 37). The host response in the innate immunity is controlled by IL-10, IL-12, and IL-
13 (20, 38, 39), in which Stat proteins are important in balancing the cytokine responses (19, 40). 
The results in the present study provide a new paradigm for the role of chemokine-chemokine 
receptor system in an innate immunity. As shown here, ablation of CCR8 function enhanced 
innate immunity in a model of sepsis, resulting in an alleviation of systemic impact during septic 
peritonitis. Sepsis and septic shock are conditions associated with high morbidity and mortality, 
and few effective therapies exist to treat these diseases. The results reported here suggest that 
therapeutic intervention targeting CCR8 may provide a novel strategy for the treatment of sepsis 
and septic shock. 
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Table 1 
 
Phagocytic and killing activities of macrophages in vitro 
Incubation (h)a CCR8+/+ Macrophages  CCR8–/– Macrophages 
1 
3 
23.0 ± 3.2 
13.8 ± 2.9 
24.3 ± 2.3 
  5.9 ± 0.9‡ 
Killing rate (%)b 40   76 
a Resident peritoneal macrophages were infected with bacteria recovered from CLP mice. After 1 h incubation, the wells were extensively washed 
and the cells were lysed with 0.5% Triton X-100 for phagocytic activity. Wells were replaced with fresh medium and cultured for an additional 2 h, 
after which the cells were lysed with 0.5% Triton X-100 for killing activity. The lysates were serially diluted and placed on TSA blood agar plates, 
and CFU within the cells were determined. Data were expressed as CFU (×103)/ml (mean±SE). bKilling rate = [1–(CFU at 3 h/CFU at 1 h)] × 100. 
The data are representative of the two individual experiments (n=6). ‡P < 0.05, when compared with CCR8+/+ macrophages (two-tailed Mann-
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Figure 1. CCR8 is expressed in resident and elicited leukocytes during CLP. A) mRNA was isolated from resident 
peritoneal macrophages from CCR8+/+ and CCR8–/– mice and subjected to quantitative RT-PCR. Data were mean from 
five mice. B) Resident peritoneal macrophages (0 h) and exudate cells at 24 h post-CLP were harvested from CCR8+/+ 
mice, and the cells were stained with anti-CCR8 IgG. A representative photograph. Arrowheads indicate infiltrating 
neutrophils. Original magnification ×400. C) Peritoneal exudate cells from CCR8+/+ and CCR8–/– mice were harvested at 
24 h after CLP, and the lysates were immunoblotted with anti-CCR8 IgG. Representative data. 
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Fig. 2 
 
                  
 
Figure 2. Mice lacking CCR8 are resistant to CLP-induced lethality. The survival rates in CCR8+/+ and CCR8–/– mice 
were monitored for 7 days after CLP (21 and 23 mice, respectively). Three different experiments were performed, and the 
data were pooled. The results were very similar in individual experiments. *P < 0.0001 vs. CCR8+/+ mice. 
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Fig. 3 
 
                                    
Figure 3. Enhanced bacterial clearance in CCR8–/– mice. A, B) At 6 and 24 h after CLP, mice were anesthetized, bled, 
and euthanized, and the peritoneal fluids were harvested. Peritoneal fluids (10 µl) (A) and peripheral blood (B) were 
serially diluted, and 5 µl of each dilution was plated on TSA blood agar plates. Twenty-eight CCR8+/+ mice (6 h: 12 mice; 
24 h: 16 mice) and 23 CCR8–/– mice (6 h: 9 mice; 24 h: 14 mice) were used. C) Mice were intraperitoneally received live 
bacteria (1×108 CFU/mouse) recovered from CCR8+/+ mice undergone CLP. At 24 h after the inoculation, mice were 
anesthetized, bled, and euthanized, and the peritoneal fluids were harvested. Peritoneal fluids (10 µl) (13 mice each) and 
peripheral blood (10 mice each) were serially diluted, and 5 µl of each dilution was plated on TSA blood agar plates. Line 
represents mean CFU count. §P < 0.01. *P < 0.0001 vs. CCR8+/+ mice. 
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Figure 4. Augmented macrophage function in CCR8–/– mice. Peritoneal cells were harvested from CCR8+/+ and CCR8–/– 
mice; the cells (1.5×106cells) were incubated for 1 h at 37°C and non-adherent cells were removed. A) For superoxide 
generation, the adherent macrophages were stimulated with LPS (1 µg/ml) for 30 min, and the cultures were assayed. For 
β-glucuronidase release and nitric oxide production, the adherent macrophages were cultured with LPS (1 µg/ml) for 24 h. 
B) The adherent macrophages were stimulated with LPS (1 µg/ml) for 24 h at 37°C, and cytokines and chemokines in the 
supernatants were measured. ‡P < 0.05. †P < 0.001. *P < 0.0001 vs. CCR8+/+ macrophages. 
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Figure 5. Altered cytokine response during CLP. At 24 h after CLP, CCR8+/+ and CCR8–/– mice (8 mice each) were 
euthanized and bled, and the plasma were harvested. Plasma levels of TNF-α, IL-10, IL-12, and IL-13 were measured. ‡P 
< 0.05 vs. CCR8+/+ mice. 
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Figure 6. CCR8–/– mice ameliorate renal injury induced by CLP. At 24 h after CLP, CCR8+/+ and CCR8–/– mice (8 mice 
each) were euthanized and bled, and the plasma were harvested. The amounts of BUN and creatinine in the plasma were 
measured. ‡P < 0.05, §P < 0.01 vs. CCR8+/+ mice. Dotted line represents the mean data obtained from untreated mice (5 
mice each). 
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